ANK2 and hypertrophic cardiomyopathy: This effect was still present when restraining the analysis to patients carrying sarcomeric protein variants (43), suggesting that ANK2 might play a role of a disease modifier in cases of hypertrophic cardiomyopathy (43, 118, 119).